MARIA RODRIGUEZ-BARRADAS to Vaccination
This is a "connection" page, showing publications MARIA RODRIGUEZ-BARRADAS has written about Vaccination.
Connection Strength
0.520
-
Effect of pneumococcal vaccination: a comparison of vaccination rates in patients with bacteremic and nonbacteremic pneumococcal pneumonia. Clin Infect Dis. 2006 Oct 15; 43(8):1004-8.
Score: 0.184
-
Protecting Healthcare Personnel in Outpatient Settings: The Influence of Mandatory Versus Nonmandatory Influenza Vaccination Policies on Workplace Absenteeism During Multiple Respiratory Virus Seasons. Infect Control Hosp Epidemiol. 2018 04; 39(4):452-461.
Score: 0.102
-
Initial and subsequent response to pneumococcal polysaccharide and protein-conjugate vaccines administered sequentially to adults who have recovered from pneumococcal pneumonia. J Infect Dis. 2008 Oct 01; 198(7):1019-27.
Score: 0.053
-
COVID-19 Breakthrough Infection after Vaccination and Substance Use Disorders: A Longitudinal Cohort of People with and without HIV Receiving Care in the United States Veterans Health Administration. AIDS Behav. 2024 Nov; 28(11):3605-3614.
Score: 0.040
-
Response of human immunodeficiency virus-infected patients receiving highly active antiretroviral therapy to vaccination with 23-valent pneumococcal polysaccharide vaccine. Clin Infect Dis. 2003 Aug 01; 37(3):438-47.
Score: 0.037
-
Impact of mandatory vaccination of healthcare personnel on rates of influenza and other viral respiratory pathogens. Infect Control Hosp Epidemiol. 2022 09; 43(9):1216-1220.
Score: 0.032
-
Protease Inhibitors Do Not Affect Antibody Responses to Pneumococcal Vaccination. Clin Vaccine Immunol. 2016 06; 23(6):524-529.
Score: 0.023
-
IgG antibody to pneumococcal capsular polysaccharide in human immunodeficiency virus-infected subjects: persistence of antibody in responders, revaccination in nonresponders, and relationship of immunoglobulin allotype to response. J Infect Dis. 1996 Jun; 173(6):1347-53.
Score: 0.023
-
Antibody to capsular polysaccharides of Streptococcus pneumoniae after vaccination of human immunodeficiency virus-infected subjects with 23-valent pneumococcal vaccine. J Infect Dis. 1992 Mar; 165(3):553-6.
Score: 0.017
-
Qualitative change in antibody responses of human immunodeficiency virus-infected individuals to pneumococcal capsular polysaccharide vaccination associated with highly active antiretroviral therapy. J Infect Dis. 2003 Mar 01; 187(5):758-68.
Score: 0.009